{"title":"自德国 GSAV 引入强制性药房报告制度以来 VIII 因子疗法的变化--三年来智能药物 ScanDoc 的回顾性数据分析","authors":"A. Rösch, D. Schmoldt","doi":"10.1055/s-0044-1779127","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":519027,"journal":{"name":"GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation","volume":"458 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The change in factor VIII therapy since the introduction of mandatory pharmacy reporting in the GSAV in Germany – a retrospective data analysis from smart medication ScanDoc over 3 years\",\"authors\":\"A. Rösch, D. Schmoldt\",\"doi\":\"10.1055/s-0044-1779127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":519027,\"journal\":{\"name\":\"GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation\",\"volume\":\"458 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0044-1779127\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1779127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The change in factor VIII therapy since the introduction of mandatory pharmacy reporting in the GSAV in Germany – a retrospective data analysis from smart medication ScanDoc over 3 years